Ginkgo bioworks holdings inc. dna
WebFind the latest Institutional Holdings data for Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) at Nasdaq.com. Ginkgo Bioworks Holdings, Inc. Class A … WebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn …
Ginkgo bioworks holdings inc. dna
Did you know?
WebGinkgo Bioworks Holdings (NYSE:DNA) shareholders have endured a 73% loss from investing in the stock a year ago. Simply Wall St. May-11-22 07:00AM. Evo Foods and … WebApr 11, 2024 · Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across …
WebJan 18, 2024 · Class Action & Lead Plaintiff Deadline: January 18, 2024 Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. (“Ginkgo” or the “Company”) (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders … WebMar 15, 2024 · Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis.
WebMar 18, 2024 · Ginkgo Bioworks Stock Down 4.2 %. Shares of NYSE:DNA traded down $0.06 on Friday, reaching $1.27. 2,628,269 shares of the company's stock were exchanged, compared to its average volume of 20,767,908. The firm has a market capitalization of $2.45 billion, a price-to-earnings ratio of -1.02 and a beta of 0.91. WebMar 1, 2024 · Ginkgo Bioworks Holdings, Inc. (DNA Quick Quote DNA - Free Report) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss ...
WebApr 10, 2024 · Ginkgo Bioworks Holdings Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $477.7 million with a -440.6% profit margin. Year-over-year quarterly sales growth most recently was -33.8%.
WebApr 8, 2024 · Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Rating) insider Reshma P. Shetty sold 37,650 shares of the stock in a transaction on Wednesday, April 5th. The stock was sold at an average price of $1.22, for a total value of $45,933.00. Following the transaction, the insider now owns 13,767,604 shares of the company's stock, valued at … litany of the holy familyWeb1 day ago · Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming … Ginkgo Bioworks was founded in 2008 with the mission to make biology easier to … Reshma Shetty co-founded Ginkgo Bioworks in 2008. As President, Chief … Clinical Enterprise, Inc. and Ginkgo Bioworks to Continue Support of Federal … The Organism Company We’re building the leading platform for cell programming. At … Use Ginkgo’s Platform to Create Your Cell Program. Your product is unique and … Announcements Taking Ginkgo Public on NYSE:DNA May 14, 2024; Creative … A New Modality. The successful development of nucleic acid vaccines … Technology Comments on DNA synthesis in Light of Our Deal with Twist November … imperfect relationship quotesWeb1 day ago · Ginkgo Bioworks Holdings Inc (DNA) Industry Biotechnology. Deal. This stock can be held in an Investment ISA and an Investment Account. Sell. $1.31. Buy. $1.34. Change. arrow-up $0.04 (+3.13%) Prices updated at 13 Apr 2024, 09:52 EDT Prices minimum 15 mins delay Prices in USD. S&P 500. arrow-up 1.33%. imperfect return electionWebApr 14, 2024 · BOSTON and KINSHASA, Democratic Republic of the Congo, April 14, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading … imperfect rhymeWebGinkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial ... imperfect rhyme finderWebThe 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 4.00, with a high estimate of 12.00 and a low estimate of 1.75. The median estimate ... litany of the holy guardian angelWebOct 17, 2024 · Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $2.63, moving +1.54% from the previous trading session. This change lagged the S&P 500's 2.65% gain on the day. imperfect rhyme examples